United Therapeutics

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• An 8,300-share sale followed an option exercise by United Therapeutics (UTHR) counsel Paul A. Mahon. (öffnet in neuem Tab)

  Stock Titan · 01.10.2026

• United Therapeutics Insider Sold Shares Worth $3,926,177, According to a Recent SEC Filing (öffnet in neuem Tab)

  marketscreener.com · 01.10.2026

• Family trusts sell 1,920 United Therapeutics (UTHR) shares under CEO Rothblatt's trading plan. (öffnet in neuem Tab)

  Stock Titan · 01.10.2026

• Form 144 UNITED THERAPEUTICS CORPORATION For: 1 October By Investing.com (öffnet in neuem Tab)

  Investing.com Canada · 01.10.2026

• United Therapeutics Corp Stock (UTHR) Moved Up by 7.26% on Oct 1: What Investors Need To Know (öffnet in neuem Tab)

  TradingKey · 01.10.2026

• Accenture, Synopsys and United Therapeutics lead midday stock moves (öffnet in neuem Tab)

  Traders Union · 01.10.2026

• This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday (öffnet in neuem Tab)

  Benzinga · 01.10.2026

• UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% (öffnet in neuem Tab)

  TradingView · 01.10.2026

• Why is United Therapeutics stock gaining today? By Investing.com (öffnet in neuem Tab)

  Investing.com Australia · 01.10.2026

• United Therapeutics Wins Yutrepia Patent Infringement Ruling (öffnet in neuem Tab)

  grafa.com · 01.10.2026

• BTIG Upgrades United Therapeutics to Buy From Neutral, Price Target is $728 (öffnet in neuem Tab)

  marketscreener.com · 01.10.2026

• United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last? (öffnet in neuem Tab)

  Yahoo Finance Singapore · 01.10.2026

• United Therapeutics Wins Patent Lawsuit Against Liquidia (öffnet in neuem Tab)

  marketscreener.com · 01.10.2026

• United Therapeutics (UTHR) Stock Jumps 13% After Crushing Court Win Over Rival (öffnet in neuem Tab)

  CoinCentral · 01.10.2026

• United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent (öffnet in neuem Tab)

  TIKR.com · 01.10.2026

• United Therapeutics Corporation wins Yutrepia PH‑ILD patent ruling (öffnet in neuem Tab)

  Mugglehead Investment Magazine · 01.10.2026

• Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• Liquidia slumps after US court rules for United Therapeutics in patent fight (öffnet in neuem Tab)

  Reuters · 30.09.2026

• United Therapeutics (UTHR) Rallies On Tyvaso Win And Massive Buyback (öffnet in neuem Tab)

  timothysykes.com · 30.09.2026

• A CEO’s trust exercises options and sells 9,500 United Therapeutics (UTHR) shares under a trading plan. (öffnet in neuem Tab)

  Stock Titan · 30.09.2026

• United Therapeutics jumps 13% on court ruling (UTHR:NASDAQ) (öffnet in neuem Tab)

  Seeking Alpha · 30.09.2026

• UTHR Stock Jumps As Tyvaso Win And Massive Buyback Fuel Momentum (öffnet in neuem Tab)

  StocksToTrade · 30.09.2026

• United Therapeutics Stock Analysis: 12% Intraday Surge Sparks Debate (öffnet in neuem Tab)

  The Cryptonomist · 30.09.2026

• United Therapeutics stock rises nearly 13% as FDA accepts supplemental Tyvaso application (öffnet in neuem Tab)

  Traders Union · 30.09.2026

• Liquidia plunges after court ruling in United Therapeutics patent fight (LQDA:NASDAQ) (öffnet in neuem Tab)

  Seeking Alpha · 30.09.2026

• Liquidia Corporation Announces District Court Ruling on United Therapeutics Patent Claims for YUTREPIA (öffnet in neuem Tab)

  Quiver Quantitative · 30.09.2026

• United Therapeutics (UTHR) Stock Pops On Tyvaso IPF Catalyst And Massive Buyback (öffnet in neuem Tab)

  StocksToTrade · 30.09.2026

• United Therapeutics (UTHR) Rallies On Tyvaso Catalyst And Big Buyback (öffnet in neuem Tab)

  timothysykes.com · 30.09.2026

• Midday Movers: ImmunityBio and United Therapeutics Lead Gains as Liquidia Tumbles (öffnet in neuem Tab)

  Business Upturn · 30.09.2026